These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2372903)

  • 81. Polymeric surface modifications of tantalum stents.
    Fontaine AB; Koelling K; Passos SD; Cearlock J; Hoffman R; Spigos DG
    J Endovasc Surg; 1996 Aug; 3(3):276-83. PubMed ID: 8800230
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pathogenesis of early thrombus formation in experimental vein graft.
    Itoh T; Kambayashi J; Tsujinaka T; Sakon M; Ohshiro T; Mori T
    Thromb Res; 1989 Feb; 53(4):357-65. PubMed ID: 2522689
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dissociation of antithrombotic and thrombocytopenic effects of D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone in rabbits.
    Dundore RL; Clas DM; VanAller GS; Habeeb PG; Pagani ED
    Thromb Res; 1994 Sep; 75(6):663-6. PubMed ID: 7831686
    [No Abstract]   [Full Text] [Related]  

  • 84. Expression of the platelet procoagulant activity in vivo in thrombus formation in an extracorporeal shunt in the rat.
    Shand RA; Smith JR; Wallis RB
    Thromb Res; 1984 Nov; 36(3):223-32. PubMed ID: 6096983
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Importance of adequate heparin dosage in arterial angioplasty in a porcine model.
    Heras M; Chesebro JH; Penny WJ; Bailey KR; Lam JY; Holmes DR; Reeder GS; Badimon L; Fuster V
    Circulation; 1988 Sep; 78(3):654-60. PubMed ID: 2970341
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Intravenous magnesium in experimental stent thrombosis in swine.
    Rukshin V; Azarbal B; Shah PK; Tsang VT; Shechter M; Finkelstein A; Cercek B; Kaul S
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1544-9. PubMed ID: 11557686
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In vitro hemocompatibility of thin film nitinol in stenotic flow conditions.
    Kealey CP; Whelan SA; Chun YJ; Soojung CH; Tulloch AW; Mohanchandra KP; Di Carlo D; Levi DS; Carman GP; Rigberg DA
    Biomaterials; 2010 Dec; 31(34):8864-71. PubMed ID: 20810163
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Experimental acute thrombotic stroke in baboons.
    Del Zoppo GJ; Copeland BR; Harker LA; Waltz TA; Zyroff J; Hanson SR; Battenberg E
    Stroke; 1986; 17(6):1254-65. PubMed ID: 3810730
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Coagulation and complement activation.
    Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
    Biomaterials; 2001 Feb; 22(4):349-55. PubMed ID: 11205438
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Experimental assessment of thrombogenicity in vascular prostheses before and during prostaglandin E1 treatment.
    Walpoth BH; Amonn A; Galdikas J; Ris HB; Schaffner T; Höflin F; Schilt W; Mettler D; Nachnbur B; Althaus U
    Eur J Vasc Surg; 1993 Sep; 7(5):493-9. PubMed ID: 8405491
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effect of endovascular irradiation on platelet recruitment at sites of balloon angioplasty in pig coronary arteries.
    Salame MY; Verheye S; Mulkey SP; Chronos NA; King SB; Crocker IR; Robinson KA
    Circulation; 2000 Mar; 101(10):1087-90. PubMed ID: 10715252
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The good, the bad and the obvious: 1993 Clemson Award for Basic Research--Keynote Lecture.
    Sefton MV
    Biomaterials; 1993 Dec; 14(15):1127-34. PubMed ID: 8130316
    [No Abstract]   [Full Text] [Related]  

  • 93. Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates.
    Tucker EI; Marzec UM; Berny MA; Hurst S; Bunting S; McCarty OJ; Gruber A; Hanson SR
    Sci Transl Med; 2010 Jun; 2(37):37ra45. PubMed ID: 20574069
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The progression of thrombus in an ex-vivo shunt model evaluated by intravascular ultrasound radiofrequency analysis.
    Komiyama N; Chronos NA; Uren NG; Moore MP; Kelly AB; Harker LA; Hanson SR; Metz JA; Yock PG; Fitzgerald PJ
    Ultrasound Med Biol; 1999 May; 25(4):561-6. PubMed ID: 10386731
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Factors influencing platelet consumption by polyacrylamide hydrogels.
    Hanson SR; Harker LA; Ratner BD; Hoffman AS
    Ann Biomed Eng; 1979; 7(3-4):357-67. PubMed ID: 121213
    [No Abstract]   [Full Text] [Related]  

  • 96. Enhanced risk of infection with device-associated thrombi.
    Mohammad SF
    ASAIO J; 2000; 46(6):S63-8. PubMed ID: 11110296
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Patency of heparinized SBS shunts at high shear rates.
    Sefton MV; Zingg W
    Biomater Med Devices Artif Organs; 1981; 9(2):127-42. PubMed ID: 7260231
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A macrofluidic model to investigate the intrinsic thrombogenicity of clinically used stents and develop less thrombogenic stents.
    Kern AY; Kreinin Y; Charle L; Epshrein M; Korin N; Mangin PH
    Heliyon; 2024 Mar; 10(5):e26550. PubMed ID: 38463800
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In-vivo testing of polymers for thrombogenicity.
    Daniels AU; Mortensen JD
    Biomater Med Devices Artif Organs; 1974; 2(4):365-77. PubMed ID: 4462865
    [No Abstract]   [Full Text] [Related]  

  • 100. Evidence that bacteria prefer to adhere to thrombus.
    Bos HM; de Boer RA; Burns GL; Mohammad SF
    ASAIO J; 1996; 42(5):M881-4. PubMed ID: 8945011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.